U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 14 results

Status:
US Approved Rx (2014)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Naltrexone is marketed as its hydrochloride salt, naltrexone hydrochloride, under the trade names Revia and Depade. A once-monthly extended-release injectable formulation is marketed under the trade name Vivitrol. VIVITROL is indicated for the treatm...
Status:
US Approved Rx (2015)
First approved in 1974

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Molindone (Moban) is a therapeutic antipsychotic, used in the treatment of schizophrenia. The exact mechanism has not been established, however, based on electroencephalogram (EEG) studies, molindone is thought to act by occupying (antagonizing) dopa...
Status:
US Approved Rx (1989)
First approved in 1964

Class (Stereo):
CHEMICAL (ABSOLUTE)



Nalbuphine is a semi-synthetic opioid agonist-antagonist used commercially as an analgesic under a variety of trade names, including Nubain and Manfine. Nalbuphine is an agonist at kappa opioid receptors and an antagonist at mu opioid receptors. Nalb...
Status:
US Previously Marketed
First approved in 1962

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Methyl anisotropinium (Anisotropine methylbromide) is a quaternary ammonium compound. Its use as treatment adjunct in peptic ulcer has been replaced by the use of more effective agents. Depending on the dose, anisotropine methylbromide may reduce the...
Status:
US Previously Marketed
First approved in 1962

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Pyrrocaine is the amide local anesthetics. It is metabolized to 2,6-xylidine. It was used mainly as an infiltration and nerve block dental anesthetic in the 1960s and favored due to its rapid onset. The potency of pyrrocaine equals that of lidocaine ...
Status:
US Approved Rx (2014)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Naltrexone is marketed as its hydrochloride salt, naltrexone hydrochloride, under the trade names Revia and Depade. A once-monthly extended-release injectable formulation is marketed under the trade name Vivitrol. VIVITROL is indicated for the treatm...
Status:
US Approved Rx (2014)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Naltrexone is marketed as its hydrochloride salt, naltrexone hydrochloride, under the trade names Revia and Depade. A once-monthly extended-release injectable formulation is marketed under the trade name Vivitrol. VIVITROL is indicated for the treatm...
Status:
US Approved Rx (2014)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Naltrexone is marketed as its hydrochloride salt, naltrexone hydrochloride, under the trade names Revia and Depade. A once-monthly extended-release injectable formulation is marketed under the trade name Vivitrol. VIVITROL is indicated for the treatm...
Status:
US Approved Rx (2015)
First approved in 1974

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Molindone (Moban) is a therapeutic antipsychotic, used in the treatment of schizophrenia. The exact mechanism has not been established, however, based on electroencephalogram (EEG) studies, molindone is thought to act by occupying (antagonizing) dopa...
Status:
US Approved Rx (1989)
First approved in 1964

Class (Stereo):
CHEMICAL (ABSOLUTE)



Nalbuphine is a semi-synthetic opioid agonist-antagonist used commercially as an analgesic under a variety of trade names, including Nubain and Manfine. Nalbuphine is an agonist at kappa opioid receptors and an antagonist at mu opioid receptors. Nalb...

Showing 1 - 10 of 14 results